Cytosorbents Corporation: dividend

CTSONASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$4.87

November 13, 2026

What Ploutos Investor adds for Cytosorbents

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 15 fiscal years, from 2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 39% since Aug 6, 2026, when the 10-Q these figures come from was filed ($7.98 then, $4.87 on Nov 13, 2026). The figures date from before that move.10-Q
  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.

Cytosorbents pays no dividend

It paid no dividend in any of the fiscal years we hold, nor over the last 12 months.

All dividend stocks

The full analysis

What do Cytosorbents's filings show?

The dividend is one part of Cytosorbents's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about CTSO's dividend

Didn't find what you were looking for?

Ask us
Does CTSO pay a dividend?

It paid no dividend in any of the fiscal years we hold, nor over the last 12 months.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.